Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Cheryl Tan

Cheryl Tan

Post-doctoral Fellow

Research Interests

My current role as a postdoctoral researcher is to create a platform for cardiotoxicity assessment by combining the usage of iPSC-cardiomyocyte with tissue engineering and high throughput imaging techniques. My research would broadly focus on utilising the platform for in vitro disease modelling, cancer drug screening and cardiotoxicity assessments. I am interested in cancer, cardiac and microvascular remodelling in disease states, and I am passionate about generating functional 3D vascularised organoids and microtissues.

I have a multidisciplinary background in cardiovascular medicine, vascular biology and tissue engineering.


I completed my Bachelor of Science (Hons) in Biomedical Sciences and Master of Research in Reproduction and Pregnancy at the University of Manchester from 2012 to 2016. I recently completed my DPhil on Cardiovascular Medicine at the University of Oxford under the supervision of Professor Paul Leeson, Associate Professor Adam Lewandowski and Assistant Professor Mariane Bertagnolli. My DPhil project focused on a unique population of endothelial progenitor cells to investigate underlying mechanisms for cardiovascular disease development in children and young adults of different birth histories and varying blood pressure profiles. As part of my DPhil, I also developed a vascularised cardiac organoid model during my DPhil.